[Prediction of immune checkpoint inhibitor therapy in urothelial carcinoma: integrated analysis of molecular patterns and clinical factors]. Hermann-Varadi M. Magy Onkol 2026;70:85-87.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hermann-Varadi M. [Prediction of immune checkpoint inhibitor therapy in urothelial carcinoma: integrated analysis of molecular patterns and clinical factors]. Magy Onkol 2026;70:85-87.
PMID: 41819065